Vaccine Therapy in Treating Patients With Stage IV Hormone Receptor Positive Breast Cancer

Clinical trial NCT01729884 · TERMINATED

Trial details

NCT number: NCT01729884
Sponsor: University of Washington
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

HER2-positive Breast Cancer Male Breast Cancer Recurrent Breast Cancer Stage IV Breast Cancer

Start date: 2012-12-01
Primary completion: 2013-06-01
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.